Skip to main content

H 13 9 (Abacavir Sulfate 300 mg (base))

Pill with imprint H 13 9 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg (base). It is supplied by Camber Pharmaceuticals, Inc.

Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for H 13 9

Abacavir Sulfate

Imprint
H 13 9
Strength
300 mg (base)
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Camber Pharmaceuticals, Inc.
National Drug Code (NDC)
31722-0557
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, hypromelloses, titanium dioxide, triacetin, ferric oxide yellow, polysorbate 80

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "H 13 9"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.